​

Zymeworks Ownership | Who Owns Zymeworks?

OverviewForecastRevenueFinancialsChartTranscripts

Zymeworks Ownership Summary

Zymeworks is owned by 3.11% institutional investors, and 96.89% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.25% of its assets in Zymeworks shares.

ZYME Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockZymeworks3.11%-96.89%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20223-96.63%2,070,987-95.65%30.06%1-97.44%--100.00%
Sep 30, 202289-20.54%47,658,739-0.20%711.38%39-40.00%254.17%
Jun 30, 2022112-6.67%47,752,434-4.39%711.09%65-17.72%2426.32%
Mar 31, 20221200.84%49,943,82218.03%811.22%7925.40%19-32.14%
Dec 31, 2021119-7.03%42,312,97614.88%811.61%63-7.35%28-3.45%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.24M3.25%3.35K
HBM Healthcare Investments AG Ord1.70M2.39%-
iShares Russell 2000 ETF1.42M2.07%-3.21K
UBS (Lux) Digital Health Equity SB USD1.42M2.06%-111.54K
BNP Paribas Health Cr Innovtr Cl Cap909.61K1.32%163.00
BNP Paribas US Small Cap Classic R867.32K1.26%50.97K
Xtrackers S&P 500 Swap ETF 1C774.42K1.12%-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C632.16K0.92%-
iShares Biotechnology ETF594.24K0.86%99.52K
Fidelity Small Cap Index571.93K0.83%-14.44K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 08, 2024Galbraith Kenneth Chair & CEOSell$64.00K
Jan 05, 2024Galbraith Kenneth Chair & CEOSell$193.85K
Jan 05, 2024Astle Christopher SVP & Chief Financial OfficerSell$48.61K
Jan 08, 2024Astle Christopher SVP & Chief Financial OfficerSell$16.05K
Jan 05, 2024Moore Paul Andrew Chief Scientific OfficerSell$79.47K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1-6
2023 Q411

ZYME Ownership FAQ

Who Owns Zymeworks?

Zymeworks shareholders are primarily institutional investors at 3.11%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Zymeworks's industry, Biotech Stocks , is 47.04%, which Zymeworks falls below.

Does Blackrock own Zymeworks?

BlackRock is not among the top 10 institutional shareholders of Zymeworks.

Who is the top mutual fund holder of Zymeworks shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Zymeworks shares, with 3.25% of its total shares outstanding invested in 2.24M Zymeworks shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools